Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1979 1
1981 1
1983 1
1984 2
1985 3
1986 1
1987 1
1988 5
1989 6
1990 7
1991 9
1992 6
1993 5
1994 12
1995 9
1996 13
1997 17
1998 11
1999 21
2000 18
2001 22
2002 27
2003 35
2004 40
2005 64
2006 73
2007 72
2008 61
2009 64
2010 83
2011 116
2012 139
2013 158
2014 188
2015 201
2016 233
2017 266
2018 328
2019 401
2020 520
2021 533
2022 651
2023 674
2024 442

Text availability

Article attribute

Article type

Publication date

Search Results

4,975 results

Results by year

Filters applied: . Clear all
Page 1
Base-editing mutagenesis maps alleles to tune human T cell functions.
Schmidt R, Ward CC, Dajani R, Armour-Garb Z, Ota M, Allain V, Hernandez R, Layeghi M, Xing G, Goudy L, Dorovskyi D, Wang C, Chen YY, Ye CJ, Shy BR, Gilbert LA, Eyquem J, Pritchard JK, Dodgson SE, Marson A. Schmidt R, et al. Among authors: ye cj. Nature. 2024 Jan;625(7996):805-812. doi: 10.1038/s41586-023-06835-6. Epub 2023 Dec 13. Nature. 2024. PMID: 38093011 Free PMC article.
Reply.
Ye C. Ye C. Arthritis Rheumatol. 2024 Jun;76(6):984-985. doi: 10.1002/art.42796. Epub 2024 Jan 28. Arthritis Rheumatol. 2024. PMID: 38221744 No abstract available.
Reply.
Ye C, Ma Z. Ye C, et al. Arthritis Rheumatol. 2024 Apr;76(4):661-662. doi: 10.1002/art.42771. Epub 2024 Jan 3. Arthritis Rheumatol. 2024. PMID: 38057142 No abstract available.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: ye c. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
4,975 results